[go: up one dir, main page]

AU2002343033A1 - Method for the preparation of pharmaceutical nanosuspensions using supersonic fluid flow - Google Patents

Method for the preparation of pharmaceutical nanosuspensions using supersonic fluid flow

Info

Publication number
AU2002343033A1
AU2002343033A1 AU2002343033A AU2002343033A AU2002343033A1 AU 2002343033 A1 AU2002343033 A1 AU 2002343033A1 AU 2002343033 A AU2002343033 A AU 2002343033A AU 2002343033 A AU2002343033 A AU 2002343033A AU 2002343033 A1 AU2002343033 A1 AU 2002343033A1
Authority
AU
Australia
Prior art keywords
preparation
fluid flow
supersonic fluid
nanosuspensions
pharmaceutical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002343033A
Inventor
Samya Belaredj
Sabine Desset
Pascal Grenier
Alain Nhamias
Guy Vergnault
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Jagotec AG
Original Assignee
Jagotec AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jagotec AG filed Critical Jagotec AG
Publication of AU2002343033A1 publication Critical patent/AU2002343033A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2002343033A 2001-11-20 2002-11-19 Method for the preparation of pharmaceutical nanosuspensions using supersonic fluid flow Abandoned AU2002343033A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0127832A GB0127832D0 (en) 2001-11-20 2001-11-20 Method for the preparation of pharmaceutical nanosuspensions
GB0127832.4 2001-11-20
PCT/GB2002/005187 WO2003045353A1 (en) 2001-11-20 2002-11-19 Method for the preparation of pharmaceutical nanosuspensions using supersonic fluid flow

Publications (1)

Publication Number Publication Date
AU2002343033A1 true AU2002343033A1 (en) 2003-06-10

Family

ID=9926133

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002343033A Abandoned AU2002343033A1 (en) 2001-11-20 2002-11-19 Method for the preparation of pharmaceutical nanosuspensions using supersonic fluid flow

Country Status (3)

Country Link
AU (1) AU2002343033A1 (en)
GB (1) GB0127832D0 (en)
WO (1) WO2003045353A1 (en)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1781253A1 (en) * 2004-07-01 2007-05-09 Warner-Lambert Company LLC Preparation of pharmaceutical compositions containing nanoparticles
DE102005005433B4 (en) 2005-02-05 2006-10-19 RST Gesellschaft für Wasserspartechnik mbH flow regulator
EP1895982A2 (en) * 2005-05-05 2008-03-12 Sanofi-Aventis U.S. LLC Stable nanoparticle formulations
JO2769B1 (en) 2005-10-26 2014-03-15 جانسين فارماسوتيكا ان. في Fast Dissociting Dopamine 2 Receptor Antagonists
US9114077B2 (en) 2006-11-17 2015-08-25 Abbvie Deutschland Gmbh & Co Kg Nanocrystals for use in topical cosmetic formulations and method of production thereof
JO2849B1 (en) 2007-02-13 2015-03-15 جانسين فارماسوتيكا ان. في Fast -Dissociating Dopamine 2 Receptor Antagonists
ES2400710T3 (en) 2007-04-23 2013-04-11 Janssen Pharmaceutica, N.V. Tia (dia) zoles as fast dissociation dopamine 2 receptor antagonists
SI2148873T1 (en) 2007-04-23 2013-01-31 Janssen Pharmaceutica, N.V. 4-alkoxypyridazine derivatives as fast dissociating dopamine 2 receptor antagonists
US8895562B2 (en) 2008-07-31 2014-11-25 Janssen Pharmaceutica Nv Piperazin-1-yl-trifluoromethyl-substituted-pyridines as fast dissociating dopamine 2 receptor antagonists
WO2014050910A1 (en) * 2012-09-26 2014-04-03 武田薬品工業株式会社 Process for producing solid particles
US12459965B2 (en) 2017-10-09 2025-11-04 Compass Pathfinder Limited Preparation of psilocybin, different polymorphic forms, intermediates, formulations and their use
GB2571696B (en) 2017-10-09 2020-05-27 Compass Pathways Ltd Large scale method for the preparation of Psilocybin and formulations of Psilocybin so produced
AU2020258086A1 (en) 2019-04-17 2021-11-11 Compass Pathfinder Limited Methods of treating neurocognitive disorders, chronic pain and reducing inflammation
CN112691087B (en) * 2021-01-25 2022-02-25 潍坊医学院 Natamycin nanoparticles and preparation method thereof

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5720551A (en) * 1994-10-28 1998-02-24 Shechter; Tal Forming emulsions
DE4440337A1 (en) * 1994-11-11 1996-05-15 Dds Drug Delivery Services Ges Pharmaceutical nanosuspensions for drug application as systems with increased saturation solubility and dissolution rate
WO1998007414A1 (en) * 1996-08-22 1998-02-26 Research Triangle Pharmaceuticals Ltd. Compositions comprising microparticles of water-insoluble substances and method for preparing same
US7255877B2 (en) * 1996-08-22 2007-08-14 Jagotec Ag Fenofibrate microparticles
JP3785932B2 (en) * 1998-05-25 2006-06-14 日本新薬株式会社 Method for producing nucleic acid-containing complex preparation
US6443610B1 (en) * 1998-12-23 2002-09-03 B.E.E. International Processing product components
CA2383233C (en) * 1999-09-21 2010-06-08 Rtp Pharma Inc. Surface modified particulate compositions of biologically active substances
AU2001257115B2 (en) * 2000-04-20 2005-01-27 Rtp Pharma Inc. Improved water-insoluble drug particle process
GB0114532D0 (en) * 2001-06-14 2001-08-08 Jagotec Ag Novel compositions

Also Published As

Publication number Publication date
GB0127832D0 (en) 2002-01-09
WO2003045353A1 (en) 2003-06-05

Similar Documents

Publication Publication Date Title
AU2001294161A1 (en) Constant pressure apparatus for the administration of fluids intravenously
AU2002240475A1 (en) Fluid flow controller
AU2003224102A1 (en) Dispensing system for fluid substances
AU2702301A (en) Blood flow controller
AU2002346937A1 (en) Method for the membrane filtration of liquids
AU2002343033A1 (en) Method for the preparation of pharmaceutical nanosuspensions using supersonic fluid flow
AU2002363995A1 (en) Fluid flow bolt system
AU2003277732A1 (en) Method for the preparation of paclitaxel solid dispersion by using the supercritical fluid process and paclitaxel solid dispersion prepared thereby
AU2001263231A1 (en) Supercritical fluid cleaning process for precision surfaces
AU2002353310A1 (en) Method for the preparation of nucleic acids
AU2002242563A1 (en) Flow monitor for rewet showers
AUPR590101A0 (en) Fluid/solid interaction apparatus
AU2002337601A1 (en) Process for the preparation of simvastatin
AU2002247750A1 (en) Flow method for the cleaning of tubes
AU2002351519A1 (en) Device for the transformation of gas/liquid slug flow to laminar flow
AU2002344706A1 (en) Fluid flow system
AU2002242228A1 (en) Method and apparatus for the preparation of aldehydes
AU7463500A (en) Method for determination of the flow rate of a liquid
AU2002351716A1 (en) A system for controlling the flow rate of a fluid
AU2002315661A1 (en) Device for the spaying of fluids
AUPR547101A0 (en) Fluid flow measurement means
AU2002240385A1 (en) Fluid injector system
AU2002321611A1 (en) Fluid flow control apparatus
AU2002230001A1 (en) Fluid flow control apparatus
AU2002252303A1 (en) Fluid atomization process

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase